Connect
← Return to Prostate Biopsy Complication
Discussion
Comment receiving replies
After watching the video the problem I see with Dr. Petteruti is that he doesn’t give any solution for people who have serious cases of prostate cancer.
Somebody who has cancer on both sides of the prostate and an extensive number of tumors elsewhere should not have the prostate treated, Just let it spread to nearby tissue?. What should they do? No solution.
Many people, these days, have come in with multiple metastasis which includes a prostate with cancer that has spread. What do you do in this case? How do you not treat people in their 50’s and 60’s so they can live into their 90s? This large surge of younger people having advanced prostate cancer is due to the fact that the medical community decided to recommend not doing PSA tests for a long time and the results are showing up now With advanced cases.
What do you do with someone who has BRCA2. If you don’t treat the cancer, it’s going to explode at some point. When somebody has BRCA2 They get cancer younger. I got it at 62 while my brother got it at 75 because he didn’t have BRCA2. He just had a father who died from it.
If the plan was to give people ADT and ARSI for life, that has a major problems since people become resistant to those drugs over time and they stop working. What do we do then, There is no magic bullet for those cases, yet.
Does Dr. Stephen Petteruti have a solution in these type of cases.
The statements about the danger of doing biopsies was very interesting. If only biopsies were not effective in huge percentage of cases. I had three of them, no side effects after the fact. MRI may be good enough to replace the biopsy as well as as tests like the PSE test. He didn’t point out concrete ways to detect prostate cancer and it’s aggressiveness. That sure would be helpful. Somebody with a Gleeson 9 or 10 sure would like to know that fact and The danger it foresees. Yes, they only get one percent but they seem to get the right one percent in a lot of cases.
I think this guy has to be in front of a group of doctors in a debate, More people than ever have been getting prostate cancer in their 50s and early 60s, And in many cases, it’s been advanced. What is the solution for these people? How are you going to get somebody to live 30 to 40 more years by not doing anything to their prostate?. We do not have the medical or scientific capability today to do any more than we’re doing now.
Replies to "After watching the video the problem I see with Dr. Petteruti is that he doesn’t give..."
Connect
Dr. Stephen Petteruti is associated with integrative and functional medicine approaches to prostate cancer.
I have heard Dr. Petteruti mention the use of advanced treatments for metastatic prostate cancer in some of his other videos and he’s definitely not against advanced treatment in these cases. However, that is not the focus of his work.
Dr. Petteruti does go into a lot of what you mention in his other videos….this thread and this particular video are about Prostate biopsy complications.
As an example, I am unaware of any detailed information from Dr. Eugene Kwon, regarding active surveillance and the positive results of the ERASE randomized clinical trial and similar studies demonstrating the efficacy of aerobic exercise and heart health diets to slow the progression of low risk prostate cancer.
Dr. Kwon simply doesn’t focus his attention on low risk prostate cancer; which includes 55-70% of ALL men initially diagnosed with PCa.
I don’t fault Dr. Kwon for his lack of expertise and knowledge of the best recommendations for low risk prostate cancer men; I simply go to someone else who has more knowledge about this particular condition, because that is my particular diagnosis.
I also read and watch a whole host of other physicians whose life work is with low risk PCa. Dr. Petteruti is just one of many.
Every man diagnosed with PCa should research and study PRIMARILY those whose expertise is focused on the PCa risk group in which they have been diagnosed; if they want to know the latest information regarding their particular diagnosis.
Of course, it’s perfectly fine to go with your own medical team’s recommendations.
My only caveat would be to ensure your team’s PRIMARY focus is with PCa patients in YOUR PARTICULAR risk category.